Han Ying

Han Ying

Chief Tech/Sci/R&D Officer at IMMUNOTECH BIOPHARM LTD

Net worth: - $ as of 30/08/2026

61 year
Health Technology
Consumer Services
Retail Trade

Profile

Han Ying was the founder of Gene Corp., founded in 2021, serving as Director.
Current jobs include Senior Vice President-Science at Gyre Therapeutics, Inc. starting in 2025, and Chief Scientific Officer at Immunotech Biopharm Ltd. Former jobs include Director at Base Therapeutics, Chief Operating Officer at Tactiva Therapeutics LLC from 2021 to 2023, and Member at T-Cure Bioscience, Inc. from 2017 to 2019.
Education includes a doctorate from Stanford University and undergraduate and graduate degrees from Peking University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
-.--%
30/03/2026 0 ( -.--% ) - $ 30/08/2026

Han Ying active positions

CompaniesPositionStart
IMMUNOTECH BIOPHARM LTD Chief Tech/Sci/R&D Officer -

Former positions of Han Ying

CompaniesPositionEnd
Chief Operating Officer 30/11/2023
Corporate Officer/Principal 31/12/2018
Founder -
See the detail of Han Ying's experience

Training of Han Ying

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

28

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Consumer Services

Consumer Services

Retail Trade

Health Technology

Health Technology

Health Technology